1. Home
  2. CANF vs DLPN Comparison

CANF vs DLPN Comparison

Compare CANF & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$3.03

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

N/A

Current Price

$1.54

Market Cap

19.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
CANF
DLPN
Founded
1994
1996
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
19.1M
IPO Year
2011
2008

Fundamental Metrics

Financial Performance
Metric
CANF
DLPN
Price
$3.03
$1.54
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$9,750.00
N/A
AVG Volume (30 Days)
37.2K
8.0K
Earning Date
03-26-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.87
EPS
N/A
N/A
Revenue
N/A
$56,699,389.00
Revenue This Year
$2,715,455.50
$14.73
Revenue Next Year
$101.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.70
52 Week Low
$0.17
$0.88
52 Week High
$10.40
$1.88

Technical Indicators

Market Signals
Indicator
CANF
DLPN
Relative Strength Index (RSI) 35.89 46.08
Support Level $0.59 $1.46
Resistance Level $4.74 $1.70
Average True Range (ATR) 0.18 0.07
MACD -0.01 -0.00
Stochastic Oscillator 12.07 42.50

Price Performance

Historical Comparison
CANF
DLPN

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

Share on Social Networks: